Results 321 to 330 of about 288,185 (387)
Angiotensin Receptor Neprilysin Inhibitors for Hypertension and Proteinuria Management During Atezolizumab/Bevacizumab Treatment for Hepatocellular Carcinoma. [PDF]
Ishikawa T+8 more
europepmc +1 more source
Autophagy in PE: Dispute, Role and Potential Target
Autophagy homeostasis serves as a central hub regulating vascular remodelling during pregnancy. It integrates maternal, genetic, and fetal factors; shapes the functions of immune cells (NK cells, macrophages, and T cells); restrains endothelial inflammatory responses (cytokines, endothelial cell, oxidative/ER stress, and protein aggregation); and ...
Miao Xu+12 more
wiley +1 more source
Chronic kidney disease prevalence and associated risk factors in hypertensive adults at Burao general hospital, Burao City, Somaliland: a cross-sectional study. [PDF]
Yosef DK, Ali YA.
europepmc +1 more source
Effects of Sacubitril/Valsartan on Blood Pressure and Proteinuria in Hypertensive Patients With Chronic Kidney Disease. [PDF]
Murakoshi M+5 more
europepmc +1 more source
Influencing Factors of Treatment Response to Rituximab in Refractory Membranous Nephropathy. [PDF]
Ma L, Yang L, Zheng J.
europepmc +1 more source
Abstract Aims To compare markers of glycaemic regulation in twin and singleton pregnancies in women with gestational diabetes mellitus (GDM). Methods A retrospective case–control study was performed. 53 twin and 212 matched singleton pregnant women with gestational diabetes were included. Data were obtained from patient files.
Ninna L. Larsen+5 more
wiley +1 more source
Staphylococcus-Induced Glomerulonephritis Following Burn Injury: A Case Report. [PDF]
Nagamura T+3 more
europepmc +1 more source
Abstract Aims Diabetic foot complications are a growing challenge for both individuals and society, underscoring the need for medical treatments and reliable risk markers. This study aimed to identify circulating metabolites associated with the prevalence and incidence of diabetic foot complications in individuals with type 1 diabetes (T1D).
Jonas A. Andersen+10 more
wiley +1 more source
Abstract Aims To evaluate whether initiating sodium‐glucose cotransporter 2 inhibitors (SGLT2i) within 3 months after a urinary tract infection (UTI) is associated with improved long‐term outcomes in patients with type 2 diabetes mellitus (T2DM), compared with dipeptidyl peptidase‐4 inhibitors (DPP‐4i).
Hsiao‐Wei Wang+5 more
wiley +1 more source